Cargando…
Potential therapeutic use of relaxin in accelerating closure of cranial bone defects in mice
Bone fractures are associated with considerable morbidity and increased mortality. A major limitation to healing is lack of bone blood flow, which is impaired by physical disruption of intraskeletal and/or periosteal vasculature by the fracture. Thus, pharmacological interventions are needed to impr...
Autores principales: | Conrad, Kirk P., Phillips, Ean G., Jiron, Jessica, Bailes, Julie, Dhar, Biswadeep, Diao, YanPeng, Aguirre, Jose Ignacio, Yarrow, Joshua F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545299/ https://www.ncbi.nlm.nih.gov/pubmed/31155858 http://dx.doi.org/10.14814/phy2.14106 |
Ejemplares similares
-
Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis
por: Messer, Jonathan G., et al.
Publicado: (2019) -
Immunoexpression of Relaxin and Its Receptors in Stifle Joints of Dogs with Cranial Cruciate Ligament Disease
por: Restucci, Brunella, et al.
Publicado: (2022) -
Relaxin'
Publicado: (1983) -
Relaxin
por: DeCherney, Alan H.
Publicado: (1982) -
Relaxin, a pleiotropic vasodilator for the treatment of heart failure
por: Teichman, Sam L., et al.
Publicado: (2008)